• View patient site
  • Order
Oncimmune
  • Our Company
    • About Oncimmune
    • Board of Directors
    • Scientific Board
    • Senior Leadership Team
    • Regulation & Quality
    • Press Releases
  • Products
    • Lung Cancer Blood Test
  • Services
    • SeroTag™ Platform
    • NavigAID
    • COVID-19 Support
  • Resources
    • Industry Publications
    • Videos
  • Investors
    • Regulatory Newsflow
    • Share Price and Tools
    • Shareholder Analysis
    • Analyst Reports
    • Results, Reports & Presentations
    • Corporate Documents
    • Corporate Governance
    • Aim Rule 26
    • Investor & Advisor Contacts
  • Contact Us
  • Our Company
    • About Oncimmune
    • Board of Directors
    • Scientific Board
    • Senior Leadership Team
    • Regulation & Quality
    • Press Releases
  • Products
    • Lung Cancer Blood Test
  • Services
    • SeroTag™ Platform
    • NavigAID
    • COVID-19 Support
  • Resources
    • Industry Publications
    • Videos
  • Investors
    • Regulatory Newsflow
    • Share Price and Tools
    • Shareholder Analysis
    • Analyst Reports
    • Results, Reports & Presentations
    • Corporate Documents
    • Corporate Governance
    • Aim Rule 26
    • Investor & Advisor Contacts
  • Contact Us

Early Cancer Detection Insights

April 13, 2016

Oncimmune USA LLC Receives 2016 Best of DeSoto Award

Read More
December 01, 2015

A Warm Welcome to Dr James Jett

Read More
oncimmune

MediCity – D6 Building
1 Thane Road
Nottingham NG90 6BH
UNITED KINGDOM

Ph: +44 1157 840 500

Otto-Hahn-Str. 15
44227
Dortmund
GERMANY
Ph: +49 231 9742 6300

Terms & Conditions Privacy Policy Cookies
twitter facebook linkedin